Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting

Geron Corp (NASDAQ: GERN) 30-day option implied volatility is at 265; compared to its 52-week range of 56 to 220 into FDA Oncologic Drugs Advisory Committee meeting.

You May Also Be Interested In

• Ginkgo Bioworks (DNA) 4K contracts of December 11 calls trade, share price up 15%
• iShares MSCI Brazil (EWZ) spreader active into Presidential elections, higher energy and commodity prices
• Mistras Group, Inc. (MG) call put ratio 36 calls to 1 put with a focus on October 22.5 and February 25 calls as share price up 3.2%